Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Sierra Oncology, Inc. (SRRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Rock Springs Capital Management LP reports a 0% stake in Sierra Oncology, Inc. |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/11/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 07/08/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/08/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/05/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 0% stake in Sierra Oncology, Inc. |
| 07/01/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 161,712 shares
@ $55, valued at
$8.9M
Disposed/sold 2,735,853 shares
@ $55, valued at
$150.5M
Disposed/sold 431,947 shares
@ $55, valued at
$23.8M
Disposed/sold 324,740 options to buy
@ $13.2, valued at
$4.3M
Disposed/sold 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Disposed/sold 75,749 options to buy
@ $13.2, valued at
$999.9k
|
|
| 07/01/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 1,511,362 shares
@ $55, valued at
$83.1M
Disposed/sold 226,704 shares
@ $55, valued at
$12.5M
Disposed/sold 1,136,250 options to buy
@ $13.2, valued at
$15M
Disposed/sold 170,437 options to buy
@ $13.2, valued at
$2.2M
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Aggarwal Gaurav (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 2,735,853 shares
@ $55, valued at
$150.5M
Disposed/sold 1,500 options to buy
@ $13.87, valued at
$20.8k
Disposed/sold 6,874 options to buy
@ $13.98, valued at
$96.1k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
Disposed/sold 1,455,384 options to buy
@ $13.2, valued at
$19.2M
|
|
| 07/01/2022 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 1,314,127 shares
@ $55, valued at
$72.3M
Disposed/sold 1,500 options to buy
@ $13.868, valued at
$20.8k
Disposed/sold 6,874 options to buy
@ $13.98, valued at
$96.1k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
Disposed/sold 871,125 options to buy
@ $13.2, valued at
$11.5M
|
|
| 07/01/2022 |
4
| Klencke Barbara (Chief Medical Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 10,000 shares
@ $55, valued at
$550k
Disposed/sold 5,000 shares
@ $55, valued at
$275k
Disposed/sold 11,744 options to buy
@ $268.2, valued at
$3.1M
Disposed/sold 2,061 options to buy
@ $263.2, valued at
$542.5k
Disposed/sold 11,399 options to buy
@ $72.8, valued at
$829.8k
Disposed/sold 1,749 options to buy
@ $58, valued at
$101.4k
Disposed/sold 4,508 options to buy
@ $94.4, valued at
$425.6k
Disposed/sold 4,999 options to buy
@ $78.4, valued at
$391.9k
Disposed/sold 167,091 options to buy
@ $13.31, valued at
$2.2M
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 30,000 options to buy
@ $16.73, valued at
$501.9k
|
|
| 07/01/2022 |
4
| Jagpal Sukhi (CFO) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 3,859 options to buy
@ $122.2, valued at
$471.6k
Disposed/sold 1,218 options to buy
@ $263.2, valued at
$320.6k
Disposed/sold 4,200 options to buy
@ $72.8, valued at
$305.8k
Disposed/sold 1,750 options to buy
@ $58, valued at
$101.5k
Disposed/sold 4,509 options to buy
@ $94.4, valued at
$425.6k
Disposed/sold 5,000 options to buy
@ $78.4, valued at
$392k
Disposed/sold 94,113 options to buy
@ $13.31, valued at
$1.3M
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 5,887 options to buy
@ $12.15, valued at
$71.5k
Disposed/sold 30,000 options to buy
@ $16.73, valued at
$501.9k
Disposed/sold 50,000 options to buy
@ $31.54, valued at
$1.6M
|
|
| 07/01/2022 |
4
| Pelzer Robert (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 671 options to buy
@ $268.2, valued at
$180k
Disposed/sold 970 options to buy
@ $82.4, valued at
$79.9k
Disposed/sold 625 options to buy
@ $45.2, valued at
$28.3k
Disposed/sold 625 options to buy
@ $130.8, valued at
$81.8k
Disposed/sold 750 options to buy
@ $26.4, valued at
$19.8k
Disposed/sold 16,686 options to buy
@ $13.98, valued at
$233.3k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Allen Andrew R (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 1,650 shares
@ $55, valued at
$90.8k
Disposed/sold 750 options to buy
@ $26.4, valued at
$19.8k
Disposed/sold 1,250 options to buy
@ $76.8, valued at
$96k
Disposed/sold 625 options to buy
@ $130.8, valued at
$81.8k
Disposed/sold 12,030 options to buy
@ $13.98, valued at
$168.2k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
|
|
| 07/01/2022 |
4
| Collard Craig A (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 13,500 shares
@ $55, valued at
$742.5k
Disposed/sold 10,000 options to buy
@ $13.88, valued at
$138.8k
Disposed/sold 6,000 options to buy
@ $18.11, valued at
$108.7k
|
|
| 07/01/2022 |
4
| DILLY STEPHEN GEORGE (CEO and President) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 5,000 shares
@ $55, valued at
$275k
Disposed/sold 520,000 options to buy
@ $14.03, valued at
$7.3M
Disposed/sold 260,000 options to buy
@ $12.15, valued at
$3.2M
Disposed/sold 92,000 options to buy
@ $16.73, valued at
$1.5M
Disposed/sold 165,000 options to buy
@ $31.54, valued at
$5.2M
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Turner William D. (Chief Reg & Tech Ops Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 75,000 options to buy
@ $12.05, valued at
$903.8k
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 12,300 options to buy
@ $16.73, valued at
$205.8k
Disposed/sold 35,000 options to buy
@ $31.54, valued at
$1.1M
|
|
| 07/01/2022 |
4
| Norrett Kevin (Chief Business Officer) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 100,000 options to buy
@ $12.05, valued at
$1.2M
Disposed/sold 49,000 options to buy
@ $12.15, valued at
$595.4k
Disposed/sold 11,700 options to buy
@ $16.73, valued at
$195.7k
Disposed/sold 35,000 options to buy
@ $31.54, valued at
$1.1M
|
|
| 07/01/2022 |
4
| Oliger Christy J. (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 18,000 options to buy
@ $17.7575, valued at
$319.6k
|
|
| 07/01/2022 |
4
| Erbez Georgia (Director) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Disposed/sold 18,000 options to buy
@ $17.7575, valued at
$319.6k
|
|
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/01/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|
|
|